Fruit fly protein acts as decoy to capture tumor growth factors

Researchers at the University of Pennsylvania School of Medicine have shown how Argos, a fruit fly protein, acts as a 'decoy' receptor, binding growth factors that promote the progression of cancer. Knowing how Argos neutralizes tumor growth may lead to new drug designs for inhibiting cancer. The study appeared online in Nature in advance of print publication.

Many types of tumors grow because of over-expression of a protein known as the epidermal growth factor receptor (EGFR) or a peptide hormone called epidermal growth factor (EGF) that binds and activates EGFR. Argos mimics EGFR by binding to EGF. But, unlike EGFR, Argos does not signal cells to grow.

In theory, surmise the researchers, a drug designed to resemble Argos could bind cancer growth factors and prevent them from signaling cancer cell growth. The investigators previously found that Argos works this way in the fruit fly, binding and neutralizing the fly version of EGF called Spitz. Inhibition of Spitz in this way is crucial for proper development of the fly eye.

"There are several ¡¥designer' cancer drugs that fight tumors driven by EGFR-like receptors, such as Herceptin, Erbitux and Tarceva," says lead author Mark A. Lemmon, PhD, Professor of Biochemistry and Biophysics. "Whereas these drugs all attack the receptor itself, an Argos-like drug would instead neutralize the cancer growth factor by mimicking a silent receptor. This is a change in paradigm for tumor-growth inhibition in this class of cancers."

Approaches using molecules that neutralize growth factors have proven themselves in other cases. The Avastin antibody works well to block the molecule that activates the vascular endothelial growth factor receptor and several drugs can block tumor necrosis factor-Ą in arthritis, including Remicade, Humira and Enbrel. An Argos-like drug would work the same way in EGFR signaling, suggests Lemmon.

In the current study, Lemmon and colleagues have worked out the details of the three-dimensional structure of Argos when it binds to Spitz. "We were surprised to find that Argos has three very similar domains that capture Spitz by surrounding it like a C-clamp," explains Lemmon. Although Argos binding to Spitz mimics the characteristic binding of EGFR to EGF, Argos and EGFR do not share the same amino acid sequence or structural similarities.

The structure of Argos was studied by X-ray crystallography, a technique that shows where each atom of the protein is located. Computer analysis is then used to put together all the data into a three-dimensional projection of the growth factor and its binding molecule.

The next step is to identify a human protein that is similar in structure to Argos. Intriguingly, Argos shares structural similarities with the human receptors for transforming growth factor ƒÒ and urokinase plasminogen activator. "There are quite a few other human proteins with similar predicted structures whose function is not yet known," says Lemmon. "We think that one of these might be a functional analogue of Argos, and we could exploit that as a drug."

Source: University of Pennsylvania

Related stories:

Personalized immunotherapy to fight HIV/AIDS
For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Sékaly from the Université de Montréal, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients. The team's findings were presented on August 5 at the XVII International AIDS Conference in Mexico City.
Novel method to create personalized immunotherapy treatments
Argos Therapeutics and Université de Montréal today announced the presentation of new information on Argos' process for developing dendritic cell-based immunotherapies for HIV. Results from the study demonstrate that loading monocyte-derived dendritic cells with combinations of HIV antigen RNA stimulates the expansion of HIV-specific T cells, which attack and kill HIV-infected cells.
Isotope analysis reveals foraging area dichotomy for Atlantic leatherback turtles
The beaches of French Guiana constitute a major reproduction site for leatherback turtles. This sea turtle, although a protected species, is threatened by human activity: it ingests plastics, get accidentally caught in fishing nets, sees its egg-laying sites destroyed and its adults hunted illegally for their meat and their eggs. Female turtles return to the same beach every two to three years to lay their eggs. What happens in the interval remains a mystery.
Satellite tracking will help answer questions about penguin travels
You could understand if a half-dozen Magellanic penguins developed a "big bird is watching" phobia before this month is over, but the surveillance really will be for their own good.
How do marine turtles return to the same beach to lay their eggs?
Marine turtles almost always return to the same beach to lay their eggs. The egg-laying sites are often far from the feeding areas and the females cross several hundred kilometers of ocean with no visual landmarks. How do they manage to return to the same spot?
NRL sensor to measure natural airglow in the upper atmosphere
The second of five Special Sensor Ultraviolet Limb Imager (SSULI) remote sensing instruments, developed by the Naval Research Laboratory, was launched on November 4, 2006 on board the DMSP F-17 satellite. SSULI is the first operational instrument of its kind and provides a new technique for remote sensing of the ionosphere and thermosphere from space. SSULI's measurements will provide scientific data supporting military and civil systems and will assist in predicting atmospheric drag effects on satellites and reentry vehicles.
Europe’s new MetOp weather satellite reaches polar orbit
For 28 years, Europe has been operating its famous Meteosat weather satellites in geostationary orbit. Today, they were joined by the first of a brand new generation of meteorological satellites. MetOp is designed to provide a closer view of the atmosphere from low earth orbit, delivering data that will improve global weather prediction and enhance our understanding of climate change.
NEC e228 3G Handset is Now Available in UK
Europe : 3, the UK’s first video mobile network, is now offering customers the new NEC e228 in shops across the UK.The NEC e228 video mobile is exclusively available on the 3 network with 3’s great value pay-as-you-go tariff, ThreePay. The NEC e228 is NEC’s sixth addition to 3’s handset portfolio and is now on sale in over 7,000 outlets across the UK.

News discussion:

Medicine & Health news